MYCOPLASM M 250 / 500 

Mycophenolate Mofetil (250mg / 500mg)

Introduction to Mycophenolate Mofetil (250mg / 500mg)

Mycophenolate Mofetil, available as MYCOPLASM M 250 / 500, is an immunosuppressive drug used primarily to prevent rejection in organ transplant patients. It comes in two strengths, 250mg and 500mg, allowing for flexible dosing to meet individual patient needs.

• Usage: Prevents organ transplant rejection
• Forms: 250mg and 500mg tablets or capsules

How MYCOPLASM M 250 / 500 Works

MYCOPLASM M 250 / 500 inhibits an enzyme necessary for the synthesis of DNA in T and B lymphocytes, which are white blood cells involved in the immune response, thereby reducing their activity and preventing organ rejection.

• Mechanism of Action: Inhibits inosine monophosphate dehydrogenase
• Effect: Suppresses immune system to prevent organ rejection

Uses of MYCOPLASM M 250 / 500

The primary use of MYCOPLASM M 250 / 500 is to prevent organ rejection after transplantation. It may also be used in the treatment of certain autoimmune diseases due to its immunosuppressive properties.

• Transplant Rejection Prevention: Used in kidney, heart, and liver transplants
• Autoimmune Diseases: May be used in conditions like lupus nephritis

Dosage and Administration

The dosing of MYCOPLASM M 250 / 500 must be carefully managed to balance the suppression of the immune system with the risk of infection or other side effects.

• Dosage: Tailored to individual needs, often starting after transplant surgery
• Administration: Taken on an empty stomach or 2 hours after eating

Side Effects of Mycophenolate Mofetil

While effective, MYCOPLASM M 250 / 500 can cause side effects, some of which may be serious.

• Common Side Effects: Gastrointestinal upset, increased risk of infections, and blood cell abnormalities
• Serious Side Effects: Increased risk of certain cancers, severe infections, and potential teratogenic effects

Interactions with Other Medications

MYCOPLASM M 250 / 500 can interact with other drugs, potentially affecting its efficacy or leading to adverse effects.

• Notable Interactions: Antacids containing magnesium and aluminum, antibiotics, and vaccines
• Monitoring: Regular blood tests to monitor drug levels and side effects

Conclusion

Mycophenolate Mofetil (MYCOPLASM M 250 / 500) plays a critical role in the management of organ transplant recipients by preventing graft rejection and treating certain autoimmune conditions. Patients on this medication need to be closely monitored for side effects and drug interactions to ensure the best possible outcomes from their treatment. A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics,

General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology.

 For further information:

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668   

 BUY NOW